Bioharvest Sciences, Inc. (TSE:BHSC) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BioHarvest Sciences Inc. has announced the early conversion of convertible debt notes into common shares, with a total value of over 16 million Canadian dollars now represented in 73,268,708 shares. The company, known for its patented Botanical Synthesis technology, also issued nearly 40 million ‘Early Exercise’ warrants as part of the conversion terms. These warrants, priced at CAD $0.3, are set to expire in late 2025.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.